Immunoglobulins for Intravenous Administration (IVIG)

VITAZ vzw·Sint-Niklaas, Belgium·EUR 12M·Expired · Jul 16, 2026·Open·Supplies·Framework

High valueStructured notice only

Original notice title

Belgium – Immunoglobulins – Immunoglobulinen voor intraveneuze toediening (IVIG)

60/100

Opportunity Score

Needs reviewLow complexity

SuppliesFrameworkExpired

Why this score?

Opportunity

60 / 100

Complexity

30 / 100

Risk factors

Minimum turnover requirement is given as placeholder €XXX; actual amount may be high, potentially excluding bidders.

Inconsistency in EU funding flag: structured data indicates EU-funded, XML notice states 'no EU funds'. This could affe...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Tender facts

Contracting authority: VITAZ vzw
Country: Belgium
CPV: 33690000 - Various medicinal products +1 more
Deadline: Jul 16, 2026
Estimated value: EUR 12M

Overview

Moderate opportunity

Key Facts

EUR 12M estimated value
Framework procurement
Supplies contract
1 lot
Duration 48 MONTH
Supply of intravenous immunoglobulins (IVIG) on an as-needed basis under a single-operator framework agreement.
Delivery to Sint-Niklaas, Belgium.

Show full summary

Open procedure framework agreement for the supply of intravenous immunoglobulins (IVIG) to VITAZ vzw in Sint-Niklaas, Belgium. Single lot, award based 100% on price, duration 48 months, maximum framework value €12,000,000 EUR. Essential tender documents available but not analyzed; key selection criterion (minimum average annual turnover) includes a placeholder (€XXX). Deadline 16 July 2026.

Risks

Minimum turnover requirement is given as placeholder €XXX; actual amount may be high, potentially excluding bidders.

Inconsistency in EU funding flag: structured data indicates EU-funded, XML notice states 'no EU funds'. This could affe...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.